212 related articles for article (PubMed ID: 22064654)
1. Genetic and epigenetic inactivation of extracellular superoxide dismutase promotes an invasive phenotype in human lung cancer by disrupting ECM homeostasis.
Teoh-Fitzgerald ML; Fitzgerald MP; Jensen TJ; Futscher BW; Domann FE
Mol Cancer Res; 2012 Jan; 10(1):40-51. PubMed ID: 22064654
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis.
Teoh-Fitzgerald ML; Fitzgerald MP; Zhong W; Askeland RW; Domann FE
Oncogene; 2014 Jan; 33(3):358-68. PubMed ID: 23318435
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion.
Teoh ML; Fitzgerald MP; Oberley LW; Domann FE
Cancer Res; 2009 Aug; 69(15):6355-63. PubMed ID: 19602586
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
5. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas.
Chen PM; Wu TC; Shieh SH; Wu YH; Li MC; Sheu GT; Cheng YW; Chen CY; Lee H
Mol Cancer Res; 2013 Mar; 11(3):261-71. PubMed ID: 23271813
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Rap1GAP through epigenetic silencing and loss of heterozygosity promotes invasion and progression of thyroid tumors.
Zuo H; Gandhi M; Edreira MM; Hochbaum D; Nimgaonkar VL; Zhang P; Dipaola J; Evdokimova V; Altschuler DL; Nikiforov YE
Cancer Res; 2010 Feb; 70(4):1389-97. PubMed ID: 20124489
[TBL] [Abstract][Full Text] [Related]
7. Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts.
Vizoso M; Puig M; Carmona FJ; Maqueda M; Velásquez A; Gómez A; Labernadie A; Lugo R; Gabasa M; Rigat-Brugarolas LG; Trepat X; Ramírez J; Moran S; Vidal E; Reguart N; Perera A; Esteller M; Alcaraz J
Carcinogenesis; 2015 Dec; 36(12):1453-63. PubMed ID: 26449251
[TBL] [Abstract][Full Text] [Related]
8. Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma.
O'Leary BR; Fath MA; Bellizzi AM; Hrabe JE; Button AM; Allen BG; Case AJ; Altekruse S; Wagner BA; Buettner GR; Lynch CF; Hernandez BY; Cozen W; Beardsley RA; Keene J; Henry MD; Domann FE; Spitz DR; Mezhir JJ
Clin Cancer Res; 2015 Apr; 21(7):1741-51. PubMed ID: 25634994
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma.
Nadal E; Chen G; Gallegos M; Lin L; Ferrer-Torres D; Truini A; Wang Z; Lin J; Reddy RM; Llatjos R; Escobar I; Moya J; Chang AC; Cardenal F; Capellà G; Beer DG
Clin Cancer Res; 2013 Dec; 19(24):6842-52. PubMed ID: 24130071
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages.
Mimae T; Okada M; Hagiyama M; Miyata Y; Tsutani Y; Inoue T; Murakami Y; Ito A
Clin Cancer Res; 2012 Feb; 18(4):945-55. PubMed ID: 22190591
[TBL] [Abstract][Full Text] [Related]
11. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Silencing of LMX1A Contributes to Cancer Progression in Lung Cancer Cells.
Wu TH; Chang SY; Shih YL; Chian CF; Chang H; Lin YW
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751497
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of manganese superoxide dismutase expression in human breast cancer cells.
Hitchler MJ; Wikainapakul K; Yu L; Powers K; Attatippaholkun W; Domann FE
Epigenetics; 2006; 1(4):163-71. PubMed ID: 17965603
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of manganese superoxide dismutase in transformed cells is associated with increased cytosine methylation of the SOD2 gene.
Huang Y; He T; Domann FE
DNA Cell Biol; 1999 Aug; 18(8):643-52. PubMed ID: 10463060
[TBL] [Abstract][Full Text] [Related]
17. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
[TBL] [Abstract][Full Text] [Related]
18. Unmasking the lung cancer epigenome.
Belinsky SA
Annu Rev Physiol; 2015; 77():453-74. PubMed ID: 25668024
[TBL] [Abstract][Full Text] [Related]
19. Extracellular superoxide dismutase and its role in cancer.
Griess B; Tom E; Domann F; Teoh-Fitzgerald M
Free Radic Biol Med; 2017 Nov; 112():464-479. PubMed ID: 28842347
[TBL] [Abstract][Full Text] [Related]
20. Abnormal hypermethylation and clinicopathological significance of Axin gene in lung cancer.
Yang LH; Xu HT; Li QC; Jiang GY; Zhang XP; Zhao HY; Xu K; Wang EH
Tumour Biol; 2013 Apr; 34(2):749-57. PubMed ID: 23192643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
